IDEXX’s Catalyst Cortisol Test: Revolutionizing Canine Endocrine Disease Diagnosis

Published: 10 Jun 2025

Author: Precedence Research

Share :

IDEXX Laboratories, Inc., a leading name in pet healthcare, has come out with its new diagnostic innovation, the Catalyst Cortisol Test. This in-clinic test can measure cortisol levels in real-time. This allows veterinarians to better handle Addison’s disease and Cushing’s syndrome as they occur in new dogs. With the expansion, Catalyst now has its third major new menu in a year, showing IDEXX’s priority in providing useful and up-to-date solutions to clinical practices.

Addison’s and Cushing’s are not easy to diagnose as their symptoms are unclear, and rapid medical care is necessary. The ability to provide results right away during the appointment helps doctors decide on treatment, treat serious cases quickly, and check a patient’s progress if they have a long-term illness. Furthermore, because this test operates with IDEXX’s VetLab Station and VetConnect PLUS, veterinarians offer more precise diagnoses, improve how they work, and give better and more prompt treatments.

Key Highlights of the Catalyst Cortisol Test

Supports Rapid Diagnosis: Essential for catching Addisonian crises early, where timely treatment can be lifesaving.

• Smart Interpretation Built In: Integrated interpretive guidance within VetLab® Station and VetConnect PLUS for instant result context and clinical decision support.
• Seamless Workflow: Load-and-go test works alone or alongside other Catalyst tests using a single sample — streamlining lab time and minimizing technician handling.
• Chronic Disease Monitoring: Enables ongoing cortisol level tracking in dogs undergoing treatment for Cushing’s, facilitating personalized care plans.

Executive Statements

Jay Mazelsky, President & CEO of IDEXX

“The Catalyst Cortisol Test is an accurate and highly requested test that addresses a critical need for our customers and equips veterinarians with built-in results interpretation for prompt action, supporting better health outcomes for dogs. Continuing to expand the Catalyst platform reinforces our Technology for Life promise, offering our customers solutions that evolve in capabilities to enhance clinical insights and patient care.”

Patty Lathan, VMD, MS, DACVIM (SAIM)

“A reliable in-house test is game-changing—it enables faster diagnosis and treatment of a life-threatening Addisonian crisis in dogs. Additionally, by delivering accurate results during the visit, it supports timely care and streamlines daily workflows for busy veterinary teams.”